Skip to main content
TEYI PHARMACEUTICAL GROUP CO.,LTD logo

TEYI PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002728 ISIN · CNE100001WK6 LEI · 300300ZUIZCFPGQWOZ61 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,596 across all filing types
Latest filing 2017-08-04 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002728

About TEYI PHARMACEUTICAL GROUP CO.,LTD

https://www.tczy.com.cn

TEYI PHARMACEUTICAL GROUP CO.,LTD. specializes in the research, development, manufacturing, and distribution of pharmaceutical products. The company's portfolio primarily consists of Chinese patent medicines and chemical drug preparations. Its flagship product, Zhike Bao Tablets, is widely recognized for treating chronic bronchitis and cough-related ailments. Beyond respiratory health, the group produces a diverse range of medications covering cardiovascular diseases, gastrointestinal disorders, and anti-infective treatments. Teyi Pharmaceutical operates modern production facilities and maintains a robust distribution network to serve healthcare providers and pharmacies. The company emphasizes the integration of traditional medicinal knowledge with modern pharmaceutical technology to enhance product efficacy and safety.

Recent filings

Filing Released Lang Actions
关于第三届监事会第十三次会议决议的公告
Regulatory Filings Classification · 95% confidence The document is an announcement of the resolutions passed at the 13th meeting of the third Supervisory Board of 特一药业集团股份有限公司. It includes the Supervisory Board's review and approval of the company's 2017 half-year report and a special report on the use and storage of raised funds. The document states that the Supervisory Board has audited and approved these reports but does not contain the actual financial statements or detailed report content itself. The document length is short (1115 characters), and it serves as a formal announcement of meeting resolutions rather than the report itself. Therefore, according to the MENU VS MEAL RULE, this document is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement about the Supervisory Board's resolutions and approvals, not the full interim report or financial statements.
2017-08-04 Chinese
独立董事关于相关事项的独立意见
Audit Report / Information Classification · 90% confidence The document is an independent director's opinion on specific matters related to the company's half-year period of 2017, including the use of raised funds and guarantees. It references regulatory guidelines and compliance but does not contain full financial statements or comprehensive financial analysis. The document length is short (1328 characters) and it is a formal opinion rather than a full report. It is not an annual or interim report, nor an earnings release. It is also not a certification or a simple announcement. The content fits best with an Audit Report / Information (AR) category, as it provides an independent opinion on compliance and internal controls related to financial matters for a specific period, without being a full annual or interim report. H1 2017
2017-08-04 Chinese
2017年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled '2017年半年度报告' which translates to '2017 Half-Year Report'. It contains detailed financial data, business overview, management discussion and analysis, asset and liability analysis, and other comprehensive information typical of an interim or quarterly report. The report period is specified as January 1, 2017 to June 30, 2017, confirming it covers a half-year period. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement. It includes financial statements, management commentary, and detailed operational data, which are characteristic of an Interim / Quarterly Report. Therefore, the appropriate classification is 'IR' (Interim / Quarterly Report). H1 2017
2017-08-04 Chinese
2017年半年度财务报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "2017 年半年度财务报告" which translates to "2017 Half-Year Financial Report." It contains detailed financial statements including consolidated and parent company balance sheets, profit and loss statements, cash flow statements, and changes in equity. The report explicitly states it is a half-year report and includes comprehensive financial data for the period ending June 30, 2017. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement. There is no indication that this is an announcement or a certification document. Therefore, this document fits the definition of an Interim / Quarterly Report (IR), which is a comprehensive financial report for a period shorter than a full fiscal year containing actual financial statements and substantive financial data and analysis. H1 2017
2017-08-04 Chinese
2017年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled '2017 年半年度报告摘要' which translates to '2017 Half-Year Report Summary'. It contains detailed financial data such as revenue, net profit, earnings per share, and asset information for the half-year period. It also discusses company operations, shareholder information, and changes in accounting policies. The presence of comprehensive financial metrics and operational analysis for a half-year period indicates this is an Interim / Quarterly Report. The document length is 3521 characters, which is relatively short, but it contains substantive financial data and analysis, not just an announcement or summary. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2017
2017-08-04 Chinese
2016年年度权益分派实施公告
Notice of Dividend Amount Classification · 95% confidence The document is titled as an '权益分派实施公告' which translates to 'Implementation Announcement of Equity Distribution' or 'Dividend Distribution Implementation Announcement'. It details the dividend payment plan for the 2016 fiscal year, including the dividend amount per share, the record date, the ex-dividend date, and the method of dividend distribution. It also references the approval of the dividend plan at the 2016 Annual General Meeting held on June 28, 2017. The document is relatively short (1658 characters) and serves as an announcement of the dividend payment details rather than a full financial report or annual report. Therefore, it fits the category of a Notice of Dividend Amount (DIV), which covers announcements of dividend amounts, payment dates, and related shareholder information.
2017-08-03 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.